Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingWages, Salaries and Other
Ratios

Rhythm Pharmaceuticals (RYTM) Long-Term Debt Repayments: 2023-2025

Historic Long-Term Debt Repayments for Rhythm Pharmaceuticals (RYTM) over the last 3 years, with Sep 2025 value amounting to $5.6 million.

  • Rhythm Pharmaceuticals' Long-Term Debt Repayments rose 66.97% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.3 million, marking a year-over-year increase of 57.08%. This contributed to the annual value of $12.9 million for FY2024, which is 74.37% up from last year.
  • According to the latest figures from Q3 2025, Rhythm Pharmaceuticals' Long-Term Debt Repayments is $5.6 million, which was up 28.58% from $4.3 million recorded in Q2 2025.
  • Rhythm Pharmaceuticals' 5-year Long-Term Debt Repayments high stood at $5.6 million for Q3 2025, and its period low was $1.3 million during Q2 2023.
  • Its 3-year average for Long-Term Debt Repayments is $3.2 million, with a median of $3.0 million in 2024.
  • Data for Rhythm Pharmaceuticals' Long-Term Debt Repayments shows a peak YoY spiked of 127.64% (in 2024) over the last 5 years.
  • Over the past 3 years, Rhythm Pharmaceuticals' Long-Term Debt Repayments (Quarterly) stood at $2.6 million in 2023, then soared by 47.94% to $3.8 million in 2024, then soared by 66.97% to $5.6 million in 2025.
  • Its last three reported values are $5.6 million in Q3 2025, $4.3 million for Q2 2025, and $4.6 million during Q1 2025.